Prime editing can potentially repair the vast majority of known disease-causing human mutations, but the technology, first developed in 2019, has not yet been widely used in the body, or in vivo, to treat genetic disease. The only clinical application of prime editing that has been publicly announced uses the technology to edit cells outside the body before…

AI summaries can be wrong sometimes—always verify important details using the source article.